Skip to main content
. 2023 Jan 25;128:335–346. doi: 10.1016/j.ijid.2023.01.018

Table 3.

Summary of vaccine safety.

Safety of the COVID-19 vaccines Odds ratio 95% confidence interval P-value Study ID
Obstetric and neonatal outcomes (vaccinated pregnant women vs unvaccinated pregnant women) Theiler et al.[16];Wainstock et al.[17];
Goldshtein et al.[12];
Rottenstreich et al.[18];
Bookstein Peretz et al.[21];
Blakeway et al.[19];
Lipkind et al.[20];
Shimabukuro et al.[26];
Kachikis et al.[22];
Trostle et al.[23];
Zauche et al.[24];
Kharbanda et al.[25];
Magnus et al.[15]
Premature delivery 0.83 0.65-1.06 0.13
Placental abruption 0.60 0.29-1.21 0.15
Postpartum hemorrhage 0.91 0.64-1.29 0.59
Miscarriage 1.12 1.00-1.27 0.05
Stillbirth 1.42 0.53-3.76 0.49
Small for gestational age infant 1.03 0.90-1.18 0.70
Local and systemic reactogenicity (pregnant women vs nonpregnant women)
Muscle pain (first dose) 0.45 0.22-0.93 0.03
Muscle pain (second dose) 1.28 0.73-2.23 0.39
Fatigue (first dose) 0.90 0.63-1.28 0.56
Fatigue (second dose) 0.89 0.65-1.22 0.48
Fever (first dose) 1.02 0.12-8.61 0.98
Fever (second dose) 0.65 0.42-1.01 0.05